Yahoo Web Search

Search results

1. • 

     Portage Biotech Shares Gain On Buying Outstanding Minority Interest In iNKT Platform

     Benzinga via Yahoo Finance· 2 years ago

     Portage Biotech Inc (NASDAQ: PRTG) acquired the remaining 22% stake in its invariant natural killer...

2. • 

     MiNK Therapeutics, Inc. (NASDAQ:INKT) Q3 2022 Earnings Call Transcript

     Insider Monkey via Yahoo Finance· 1 year ago

     MiNK Therapeutics, Inc. (NASDAQ:INKT) Q3 2022 Earnings Call Transcript November 6, 2022 Operator:...

3. • Q4 2023 Mink Therapeutics Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 2 months ago

     Participants Zack Armen; Head of IR; MiNK Therapeutics, Inc. Jennifer Buell; President & CEO; MiNK Therapeutics, Inc. Marc Van Dijk; Chief Scientific Officer; MiNK Therapeutics, Inc. Christine ...

4. • MiNK Therapeutics Inc (INKT) Reports Q3 2023 Results: Clinical Progress Amid Financial Challenges

     GuruFocus.com via Yahoo Finance· 7 months ago

     MiNK Therapeutics Inc (NASDAQ:INKT) presented promising data for its allogeneic iNKT cell therapy, agenT-797, with durable benefits in solid tumor cancers. The company reported a decrease in ...